跳至主要内容
临床试验/NCT05225220
NCT05225220已完成不适用

Multimodal Investigation of Post COVID-19 in Females: A Pilot Study

Casa Colina Hospital and Centers for Healthcare2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Change in Picture Sequence Memory Test (PSMT) scores

研究概览

简要总结

The purpose of this study is to investigate the effects of transcutaneous vagus nerve stimulation (t-VNS) on Long Covid symptoms in females and to identify factors influencing susceptibility and recovery-particularly in the cognitive domain, as over 80% of long-haulers experience "brain fog".

详细描述

Long COVID is a post-viral illness estimated to affect 10-30% of COVID-19 patients. Post-COVID symptoms can last for months and affect multiple organs. Major risk factors of long COVID include the female sex and pre-existing anxiety/depression. Because women already have higher rates of anxiety/depression, the combined risks could exacerbate their susceptibility.

Based on the rationale that long COVID symptoms significantly overlap with functions of the vagus nerve, which serves as a conduit between the brain and body, the investigators propose to use non-invasive transcutaneous vagus nerve stimulation (t-VNS) as a novel treatment for long COVID in 20 female participants.

This pilot study will utilize a holistic approach by integrating neuromodulation, neuroimaging, genetics, blood biomarkers, behavioral assessments, and wearable technology to examine the effects of VNS therapy on post COVID-19 symptoms and to identify factors that influence susceptibility and recovery, particularly in the cognitive domain, as over 80% of long-haulers report experiencing "brain fog" (i.e., cognitive disruptions).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Biologically female at birth and at time of enrollment
  • At least 18 years of age or older
  • Experiencing persistent symptoms of brain fog/cognitive impairment beyond 3 months of COVID-19 infection that are not explained by an alternative diagnosis

排除标准

  • Not t-VNS compatible (e.g. pacemaker implants)
  • Not MRI compatible (e.g. metal implants, claustrophobia)
  • Currently pregnant
  • Long COVID without cognitive impairment
  • History of neurological conditions prior to COVID-19 infection

结局指标

主要结局

Change in Picture Sequence Memory Test (PSMT) scores

时间窗: At baseline, at week 3, and at week 7

PSMT is a non-verbal NIH Toolbox Cognition Battery assessment that measures a participant's episodic memory.

Change in Dimensional Change Card Sort Test (DCCS) scores

时间窗: At baseline, at week 3, and at week 7

DCCS is a non-verbal NIH Toolbox Cognition Battery assessment that measures a participant's executive functioning.

Change in Flanker Inhibitory Control and Attention Test (Flanker) scores

时间窗: At baseline, at week 3, and at week 7

Flanker is a non-verbal NIH Toolbox Cognition Battery assessment that measures both a participant's attention and inhibitory control.

Change in Pattern Comparison Processing Speed scores

时间窗: At baseline, at week 3, and at week 7

Pattern Comparison Processing Speed is a non-verbal NIH Toolbox Cognition Battery assessment that measures a participant's processing speed.

Change in List Sorting Working Memory scores

时间窗: At baseline, at week 3, and at week 7

List Sorting Working Memory is an oral NIH Toolbox Cognition Battery assessment that measures a participant's working memory.

次要结局

  • Change in Magnetic Resonance Imaging (MRI)(At baseline and at week 3)
  • Change in PROMIS Sleep Disturbance scores(At baseline, at week 3, and at week 7)
  • Change in Sniffin' Sticks olfactory performance(At baseline, at week 3, and at week 7)
  • Change in resting state Electroencephalograph (EEG) signals(At baseline and at week 3)
  • Change in blood marker levels(At baseline and at week 3)
  • Change in Becks Depression Inventory (BDI) scores(At baseline, at week 3, and at week 7)
  • Change in BURNS Anxiety Inventory scores(At baseline, at week 3, and at week 7)
  • Change in Fatigue Severity Scale scores(At baseline, at week 3, and at week 7)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amy Zheng

Research Scientist

Casa Colina Hospital and Centers for Healthcare

研究点 (2)

Loading locations...

相似试验